These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38090570)

  • 21. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness.
    Mishima Y; Tsuno NH; Matsuhashi M; Yoshizato T; Sato T; Ikeda T; Watanabe-Okochi N; Nagura Y; Sone S; Kurokawa M; Okazaki H
    Transfus Apher Sci; 2015 Feb; 52(1):112-21. PubMed ID: 25467707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant immune response to HLA-B57/B58 molecules after platelet transfusion.
    Coombs J; Ben Hassen L; Leclerc M; Tamagne M; Pannetier L; Khelfa M; Delorme A; Bocquet T; Maury S; Pirenne F; Ansart-Pirenne H; Vingert B
    Transfusion; 2020 Dec; 60(12):2807-2814. PubMed ID: 33037638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.
    Couvidou A; Rojas-Jiménez G; Dupuis A; Maître B
    Front Immunol; 2023; 14():1125367. PubMed ID: 36845153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells.
    Sayeh E; Sterling K; Speck E; Freedman J; Semple JW
    Blood; 2004 Apr; 103(7):2705-9. PubMed ID: 14656873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
    Semple JW; Speck ER; Cosgrave D; Lazarus AH; Blanchette VS; Freedman J
    Blood; 1999 Jan; 93(2):713-20. PubMed ID: 9885234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management.
    Pavenski K; Freedman J; Semple JW
    Tissue Antigens; 2012 Apr; 79(4):237-45. PubMed ID: 22385314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of HLA antibody generation after receipt of Mirasol versus standard platelets in the MIPLATE randomized trial.
    Kaidarova Z; Di Germanio C; Custer B; Norris PJ
    Transfusion; 2023 Apr; 63(4):791-797. PubMed ID: 36840440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization.
    Nelson KA; Aldea GS; Warner P; Latchman Y; Gunasekera D; Tamir A; Gernsheimer T; Bolgiano D; Slichter SJ
    Transfusion; 2019 Nov; 59(11):3396-3404. PubMed ID: 31608454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
    Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
    Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN
    Poston JN; Sugalski J; Gernsheimer TB; Marc Stewart F; Pagano MB
    Vox Sang; 2020 May; 115(4):334-338. PubMed ID: 32080868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics.
    Chen X; Zhao Y; Lv Y; Xie J
    Platelets; 2024 Dec; 35(1):2306983. PubMed ID: 38314765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of platelet alloimmunization.
    Slichter SJ
    Prog Clin Biol Res; 1986; 211():83-116. PubMed ID: 3515365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A; Pavenski K
    Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
    J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of platelet-alloimmunization with cyclosporin A in a patient with aplastic anemia.
    Yamamoto M; Ideguchi H; Nishimura J; Nawata H; Inaba S; Tokunaga K; Kiyokawa H; Maeda Y
    Am J Hematol; 1990 Mar; 33(3):220-1. PubMed ID: 2301381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model.
    Slichter SJ; Pellham E; Bailey SL; Christoffel T; Gettinger I; Gaur L; Latchman Y; Nelson K; Bolgiano D
    Blood; 2017 Aug; 130(8):1052-1061. PubMed ID: 28705838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.